個案總覽
依發行單位、學門或關鍵字,找到適合的教學個案。
-
PharmaCo - Presentation
Presentation for product 8B20M053. -
PharmaCo
PharmaCo was a large, multinational, integrated pharmaceutical company. Its board of directors was meeting to discuss a possible friendly merger with a complementary competitor and to review a quarterly cybersecurity report. However, before either of these discussions could begin, PharmaCo’s chief financial officer interrupted with news that the company’s customer database had been encrypted by hackers in a ransomware attack and a ransom of $25,000 in Bitcoin had been demanded. Unfortunately, this was the first in a series of cyber attacks affecting the organization. The board of directors must increasingly deal with a number of issues brought by management and make some critical decisions in overseeing this crisis. -
PharmaCo: Inject 1—Ransomware
Additional Supplement to accompany 9B20M053. -
PharmaCo: Inject 2—Email Theft
Additional Supplement to accompany 9B20M053. -
PharmaCo: Inject 3—Phi Theft
Additional Supplement to accompany product 9B20M053. -
PharmaCo: Inject 4—Large Breach and Phi Theft
Additional Supplement to accompany 9B20M057. -
PharmaCo: Inject 5—Malware Infection
Additional Supplement to accompany 9B20M058. -
PharmaCo
PharmaCo was a large, multinational, integrated pharmaceutical company. Its board of directors was meeting to discuss a possible friendly merger with a complementary competitor and to review a quarterly cybersecurity report. However, before either of these discussions could begin, PharmaCo's chief financial officer interrupted with news that the company's customer database had been encrypted by hackers in a ransomware attack and a ransom of $25,000 in Bitcoin had been demanded. Unfortunately, this was the first in a series of cyber attacks affecting the organization. The board of directors must increasingly deal with a number of issues brought by management and make some critical decisions in overseeing this crisis.